Publications by authors named "G Sglavo"
Background: Cesarean scar ectopic pregnancy is a type of ectopic pregnancy in which the fertilized egg is implanted in the muscle or fibrous tissue of the scar after a previous cesarean delivery. The condition can be catastrophic if not managed on time and can lead to significant morbidity and mortality. Several approaches have been studied for the management of cesarean scar ectopic pregnancy in women who opted for termination of pregnancy with no consensus on the best treatment modality reached so far.
View Article and Find Full Text PDFBackground: Caesarean scar pregnancy (CSP) is a type of ectopic pregnancy where the fertilised egg is implanted in the muscle or fibrous tissue of the scar after a previous caesarean section. Management options for women who opted for termination of CSP include sharp curettage, dilation and evacuation (D&E), excision of trophoblastic tissues, local or systemic administration of methotrexate, bilateral hypogastric artery ligation, and selective uterine artery embolisation with curettage and/or methotrexate administration. Recently hysteroscopic resection has also been proposed as an alternative option.
View Article and Find Full Text PDFArticle Synopsis
- - A study was conducted on 249 fetuses with increased nuchal translucency (NT) or cystic hygroma to assess the effectiveness of karyotype, chromosome microarray analysis (CMA), and non-invasive prenatal testing (NIPT) in detecting chromosome anomalies.
- - The findings revealed 103 chromosomal anomalies were identified through karyotyping, while CMA detected additional pathogenic and likely pathogenic copy number variants, highlighting the complexity of interpreting genetic results.
- - The study concluded that NIPT is not reliable for detecting anomalies associated with ultrasound signs, and while CMA is valuable as a follow-up to rapid aneuploidy testing, karyotype analysis should not be overlooked.
Objectives: To compare uterine rupture rates in women having a medical abortion receiving gemeprost alone to those receiving mifepristone plus gemeprost.
Study Design: We reviewed the records of women undergoing medical abortion at 13 0/7-23 6/7 weeks from January 2007 to December 2014 at a single center in Italy. Prior to January 2011, we used gemeprost 1 mg vaginally every 3 h up to a maximum of five doses.
Hindbrain morphometry and choroid plexus position in differential diagnosis of posterior fossa cystic malformations.
Ultrasound Obstet Gynecol
August 2019
Objective: To assess the differential diagnostic significance of a series of quantitative and qualitative variables of the cerebellar vermis in fetuses with posterior fossa cystic malformation, including Dandy-Walker malformation (DWM), vermian hypoplasia (VH) and Blake's pouch cyst (BPC).
Methods: This was a retrospective study of confirmed cases of DWM, VH and BPC, diagnosed at the Fetal Medicine and Surgery Unit of the Federico II University between January 2005 and June 2013 or the Fetal Medicine and Surgery Unit of G. Gaslini Hospital between July 2013 and September 2017.